chrisvoncsefalvay/vaers-outcomes huggingface dataset:
intense pain bone and joint; intense pain bone and joint; severe pain; 10/ 10 pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient received BNT162b2 (BNT162B2), on 18May2021 as dose 2, single (Lot number: EW0168) at the age of 42 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing); "Surgery" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION oral taken for attention deficit hyperactivity disorder (ongoing); GUAIFENESIN oral taken for attention deficit hyperactivity disorder (ongoing). Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: Unknown, Anatomical location: Arm), administration date: 27Apr2021, when the patient was 42-year-old, for COVID-19 immunisation, reaction(s): "a little tired". The following information was reported: BONE PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 18May2021, outcome "recovered" and all described as "intense pain bone and joint"; PAIN (non-serious) with onset 18May2021, outcome "recovered", described as "severe pain; 10/ 10 pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of bone pain, arthralgia, pain.  Additional information: The patient did not undergo any specific relevant test for thromboembolic events with thrombocytopenia. Second and third doses of vaccine were followed by the most intense pain. It feel like the patients bones were being crushed by a machine, 10/10 pain. Particularly in the joints (hips, elbows). If the patient had not had medication left over from a past surgery, would have gone to the ER. It also was not particularly effective, since caught covid 3 times, but that was probably not relevant. No apparent lasting effects once pain subsided.; Sender's Comments: Linked Report(s) : 202201236731 Same patient/ vaccine, different dose/AE;US-PFIZER INC-202201236731 Same patient/ vaccine, different dose/AE;
chest discomfort / chest pressure; vaccination adverse reaction; chest pain; shortness of breath; discomfort; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest discomfort / chest pressure), IMMUNISATION REACTION (vaccination adverse reaction), CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and DISCOMFORT (discomfort) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (chest discomfort / chest pressure), IMMUNISATION REACTION (vaccination adverse reaction), CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and DISCOMFORT (discomfort). At the time of the report, CHEST DISCOMFORT (chest discomfort / chest pressure), IMMUNISATION REACTION (vaccination adverse reaction), CHEST PAIN (chest pain), DYSPNOEA (shortness of breath) and DISCOMFORT (discomfort) outcome was unknown. No concomitant and treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
76 y.o. male who presents with complaint of right-sided weakness  facial droop.  Time of onset unknown.  Patient has right arm drift, able to raise the right leg against gravity but not against resistance right facial droop.  Patient is alert and able to answer questions.  Blood pressure is elevated 205/115
On 10/27/2000, pt was referred to PCP for evaluation of following symptoms: pain, redness, induration about 3cm in diameter. PCP's dx: mild cellulitis. No treatment required.
GI sx;w/in a few days c/o neuro signs & sx described as pain, fatigue, sleeplessness, weakness, GI sx;no complaint of erythema or rash;fibromyalgia;exp arthralgia;c/o wide spread joint discomfort;stiffness;misjudging step;
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 19-JAN-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot number M033906, expiration date 20-JUL-2018 (dose, route and anatomical location were not reported) for prophylaxis (incorrect product storage). The vaccine was exposed to temperature of -5 Fahrenheit (F) (-20 Celsius (C)) and to the lowest recorded temperature of -14 F (-25C) during 4 hours and 5 minutes. The storage type was reported as "data logger". There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1701USA012890: US-009507513-1701USA013083: US-009507513-1701USA013084: US-009507513-1701USA013085: US-009507513-1701USA013086: US-009507513-1701USA013087: US-009507513-1701USA013088: US-009507513-1701USA013089: US-009507513-1701USA013090: US-009507513-1701USA013091: US-009507513-1701USA013092: US-009507513-1701USA013093: US-009507513-1701USA013094: US-009507513-1701USA013095: US-009507513-1701USA013096: US-009507513-1701USA013097: US-009507513-1701USA013098: US-009507513-1701USA013099: US-009507513-1701USA013100: US-009507513-1701USA013101: US-009507513-1701USA013102: US-009507513-1701USA013103: US-009507513-1701USA013104: US-009507513-1701USA013105: US-009507513-1701USA013106: US-009507513-1701USA013107: US-009507513-1701USA013109: US-009507513-1701USA013110: US-009507513-1701USA013082.
pain when lifting left arm; Fever; body aches and pain; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021 at 9:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness). On 15-Mar-2021, PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 99.7 (High) 99.7 degree F.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Updated first dose information and changed event outcome from unknown to recovered/resolved.
fever of 103 within 24 hours, fine rash that started on head and spread over torso over 24 hours. More fussy. Decrease in appetite
pt broke out in large welts/hive on left arm and they spread over to his right arm
Frozen shoulder. Intense soreness. Saw Ortho Dr. Had X-ray, had MRI, now in PT. HAVE LOST ALL RANGE OF MOTION, pain won't let up.
Headache; Fatigue; Muscle pain at injection site; This is a spontaneous report received from a non-contactable consumer(patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE - solution for injection; lot number- FC3182, expiry date not reported) via an unspecified route of administration, on 22Aug2021 15:30, at the age of 38-year-old, at dose number unknown, single for covid-19 immunisation in a pharmacy or drug store. The patient did not have any medical history. The concomitant medications include aleeve and sumatripta. The patient is not pregnant at the time of vaccination. The patient did not receive other vaccine in four weeks. The patient experienced headache, fatigue, muscle pain at injection site on an unspecified date. The patient did not have prior COVID vaccination and was tested for post vaccination. The patient tested binax rapid test on 23Aug2021 and had negative result. The patient did not receive treatment in response to the events. The outcome of the events was recovering at the time of report.  No follow-up attempts are possible. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 66-year-old female patient who received SHINGRIX (batch number 957J3, expiry date 15th November 2020) for prophylaxis. Concomitant products included Atorvastatin and Levothyroxine. On 30th July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 30th July 2018, less than a day after receiving SHINGRIX, the patient experienced chills, fluid retention, injection site erythema, injection site swelling, fever and headache. On an unknown date, the outcome of the chills, fluid retention, injection site erythema, injection site swelling, fever and headache were not recovered/not resolved. It was unknown if the reporter considered the chills, fluid retention, injection site erythema, injection site swelling, fever and headache to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in left deltoid. The registered pharmacist reported that, she spoke to the patient on the phone, and the patient had not been seen by the pharmacy or her physician.
Patient had a fever of 100.8 with headache and body aches.  Fever spiked to 102.8 by 2:00 PM. He was given ibuprofen and fluids.  His fever was 99.5 by 11/04/2015 at 7:00 AM but he still felt unwell.  By 11/04/2015 at 7:00 PM he had no fever.  By 11/05/2015 at 7:00 AM he felt fine.
same reaction that she had 4 weeks ago; Chills; Diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I experienced  shortness of breath when doing basic activity and blood clots in my knees that traveled to my lungs.
Pt received 2nd dose of the 21-day Pfizer vaccine today. While in observation, pt reported feeling light-headed and scratchy throat.  Observers alerted medical staff who escorted pt to recovery room for support and continued observation.    BP: 150/79 @ 10:00am/ 1135/70 @ 10:30am SPO2: 100% on RA Pulse: 79 Administerd 25mg Benadryl, PO   Pt reported feeling improved after about 10 minutes.  We continued observation of pt for another 30 min.    Of note: pt is currently receiving chemotherapy infusions. I will attempt to find her oncologist and ml the chart, if possible.    Compass report and VAERS report filed.    RN
low grade fever of 100.9 degrees Fahrenheit; experiencing pain in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever of 100.9 degrees Fahrenheit) and MYALGIA (experiencing pain in his arm) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (low grade fever of 100.9 degrees Fahrenheit) and MYALGIA (experiencing pain in his arm). At the time of the report, PYREXIA (low grade fever of 100.9 degrees Fahrenheit) and MYALGIA (experiencing pain in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Rheumatoid Arthritis; I'm an immunecompromise person; This spontaneous case was reported by a patient and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) and IMMUNODEFICIENCY (I'm an immunecompromise person) in a 65-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) (seriousness criterion medically significant) and IMMUNODEFICIENCY (I'm an immunecompromise person) (seriousness criterion medically significant). At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) and IMMUNODEFICIENCY (I'm an immunecompromise person) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Patient got primary dose and first booster of Moderna. After the patient received the 1st booster, immune system did respond with double vision for 10 days and now patient was an immunocompromised person. Patient had Rheumatoid Arthritis.  No treatment medication reported. Company comment- This spontaneous case concerns a 65-year-old patient of unknown gender with no medical history reported, who experienced the unexpected serious (medically significant) events Rheumatoid Arthritis (AESI) and immunodeficiency. A dose of mRNA-1273.222 (Original/Omicron BA.4/5) vaccine, given as a booster dose of COVID vaccine schedule, was administered. Latency unknown as the onset date of the events and vaccination date were not specified. Details of symptoms, clinical course, investigation reports and treatment were not provided. The benefit-risk relationship mRNA-1273.222 (Original/Omicron BA.4/5) vaccine is not affected by this report.
A report has been received from a Health Professional concerning a 16 year old, Female subject, who had been receiving Nasal FLUMIST. FLUMIST started on 20-Oct-2012. The patient experienced positive for flu A which started on 11-Jan-2013. The patient recovered from the event of positive for flu A on an unspecified date. The report was considered to be non-serious.
Patient complaining leg hurt on spot of one shot out of three.  Would not let me each take off bandaid or touch thigh around area.  Next night took off bandaid, injection site red around it and when I touch it there was a huge lump about the size of a dime.  Touching site caused screaming and crying for patient for approximately 2 minutes.  Lump there for 6 days and hurt patient for 5 days and patient was just all around fussy.
Within 20 minutes I had a severe anaphylactic reaction blood pressure dropping, pulse rapid, flushing of the face and was unresponsive, EPIPEN was injected in left thigh and transported by ambulance to ER. Given steroids, BENADRYL, monitored. Sent home, next day tightness in chest, fullness in that and flushing presented again, went back to ER given BENADRYL and steroids, given prescription for prednisone 3 times a day for 5 days and BENADRYL 50 mg every 6hours for 2 days. Still awaiting final outcome.
Left leg swelling after immunizations on 3/18/16 fever. Came in to Dr's office on 3/21/16.
PATIENT STATES RIGHT ARM PAINFUL SINCE ADMINISTRATION AND NOW PAIN RADIATING FROM SHOULDER TO NECK (ESPECIALLY PAINFUL WHEN USING ARM.
Pt was given Influenza virus vaccine instead of Hepatitis B on 12-30-08. She was then given Hepatitis B on 01-2-09.
This spontaneous report was received from a male patient of unknown age. On 25-SEP-2013 the patient was vaccinated with one shot of ZOSTAVAX by injection  (route and lot # not reported). On 25-SEP-2013 or 26-SEP-2013, the patient experienced itching and swelling of the injection site after receiving ZOSTAVAX. The patient spoke with an unspecified pharmacist for medical attention. The outcome of itching and swelling of the injection site was unknown. Additional information is not expected.
I had syncopal episodes and was very weak, administered IV fluids received 3 hours of heart monitoring, blood pressure and blood sugar. Went to cardiologist 12 lead EKG, 2 week heart monitor Zio-patch. Decreases blood pressure medication, blood work drawn, one week later had blood work repeated.
T102 febrile, not eating, runny nose, cough, sleeping all day;
August 27-2021 - 1ST COVID 19- SHOT GIVEN - JOHNSON AND JOHNSON - experienced soreness at the shot site- took Tylenol and increased fluid intake: water, Gatorade and juice Aug 27-2021 through Sept 10 2021 - Experiencing hot flashes, occasional headaches.  Continued taking Tylenol for the headache symptoms. September 27-2021 - Red rash developing on Upper arms - starting to spread out - no fever. October 1-2021 - Experiencing skin issues on shot site - not eczema.  Developed hives on upper back and upper chest.  Taking OTC Benadryl to help with the itchy symptoms.  Noticing small cuts around my nails and hands. Oct 1
Covid arm- quite itchy rash at injection site, irregular shape but roughly 3 inch diameter, and slightly swollen
nausea, heart racing, vomiting, diarrhea, chills, hives
tested positive for Covid-19 after getting the first shot; missed second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose). At the time of the report, COVID-19 (tested positive for Covid-19 after getting the first shot) and PRODUCT DOSE OMISSION ISSUE (missed second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
A report was received from a health care professional on 11/10/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update reported was received from a health care professional concerning a 76 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. NO adverse symptoms were exhibited at the time of reporting. No follow up pending.
Fever of 100.6, severe pain at injection site, & large area of erythema.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 22-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided. No relevant concomitant medications were reported. Treatment details also included arthritis cream.   Reporter did not allow further contact
This spontaneous report was received from a health care professional refers to an unspecified patient of unknown demographics. On an unknown date the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # J007943; expiry: 05-FEB-2016) (dose #, route and frequency unspecified) (incorrect product storage). No concomitant medications were reported. No adverse effects reported. No further information provided. This is one of several reports received from the same source. Additional information has been requested.
Pt when given the vaccine felt he was going to faint. His hands went numb. He felt he could not keep his eyes open. Pt was made to sit at Pharmacy under observation for sometime. Pt felt perfectly fine in few minutes.
Very sore arm the next day that went away a couple days later only to come back a week after very painful and swollen. The ringing in the ears started right after I walked out of the hospital and has only gotten louder since.
Suspected shingles; This case was reported by a other health professional via sales rep and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th October 2019, the patient received the 1st dose of Shingrix. On 15th October 2019, 7 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. On the reporting date, the patient presented with suspected shingles. The patient was sent for cultures for diagnosis.  The clinic would follow up with Glaxosmithkline with outcome.